Literature DB >> 22131357

Pulmonary capillary wedge pressure augments right ventricular pulsatile loading.

Ryan J Tedford1, Paul M Hassoun, Stephen C Mathai, Reda E Girgis, Stuart D Russell, David R Thiemann, Oscar H Cingolani, James O Mudd, Barry A Borlaug, Margaret M Redfield, David J Lederer, David A Kass.   

Abstract

BACKGROUND: Right ventricular failure from increased pulmonary vascular loading is a major cause of morbidity and mortality, yet its modulation by disease remains poorly understood. We tested the hypotheses that, unlike the systemic circulation, pulmonary vascular resistance (R(PA)) and compliance (C(PA)) are consistently and inversely related regardless of age, pulmonary hypertension, or interstitial fibrosis and that this relation may be changed by elevated pulmonary capillary wedge pressure, augmenting right ventricular pulsatile load. METHODS AND
RESULTS: Several large clinical databases with right heart/pulmonary catheterization data were analyzed to determine the R(PA)-C(PA) relationship with pulmonary hypertension, pulmonary fibrosis, patient age, and varying pulmonary capillary wedge pressure. Patients with suspected or documented pulmonary hypertension (n=1009) and normal pulmonary capillary wedge pressure displayed a consistent R(PA)-C(PA) hyperbolic (inverse) dependence, C(PA)=0.564/(0.047+R(PA)), with a near-constant resistance-compliance product (0.48±0.17 seconds). In the same patients, the systemic resistance-compliance product was highly variable. Severe pulmonary fibrosis (n=89) did not change the R(PA)-C(PA) relation. Increasing patient age led to a very small but statistically significant change in the relation. However, elevation of the pulmonary capillary wedge pressure (n=8142) had a larger impact, significantly lowering C(PA) for any R(PA) and negatively correlating with the resistance-compliance product (P<0.0001).
CONCLUSIONS: Pulmonary hypertension and pulmonary fibrosis do not significantly change the hyperbolic dependence between R(PA) and C(PA), and patient age has only minimal effects. This fixed relationship helps explain the difficulty of reducing total right ventricular afterload by therapies that have a modest impact on mean R(PA). Higher pulmonary capillary wedge pressure appears to enhance net right ventricular afterload by elevating pulsatile, relative to resistive, load and may contribute to right ventricular dysfunction.
© 2011 American Heart Association, Inc.

Entities:  

Mesh:

Year:  2011        PMID: 22131357      PMCID: PMC3264431          DOI: 10.1161/CIRCULATIONAHA.111.051540

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  19 in total

1.  Isolated aorta setup for hemodynamic studies.

Authors:  P Sipkema; R D Latham; N Westerhof; B J Rubal; D M Slife
Journal:  Ann Biomed Eng       Date:  1990       Impact factor: 3.934

2.  Use of pulse pressure method for estimating total arterial compliance in vivo.

Authors:  N Stergiopulos; P Segers; N Westerhof
Journal:  Am J Physiol       Date:  1999-02

3.  Sildenafil citrate therapy for pulmonary arterial hypertension.

Authors:  Nazzareno Galiè; Hossein A Ghofrani; Adam Torbicki; Robyn J Barst; Lewis J Rubin; David Badesch; Thomas Fleming; Tamiza Parpia; Gary Burgess; Angelo Branzi; Friedrich Grimminger; Marcin Kurzyna; Gérald Simonneau
Journal:  N Engl J Med       Date:  2005-11-17       Impact factor: 91.245

4.  Tricuspid annular displacement predicts survival in pulmonary hypertension.

Authors:  Paul R Forfia; Micah R Fisher; Stephen C Mathai; Traci Housten-Harris; Anna R Hemnes; Barry A Borlaug; Elzbieta Chamera; Mary C Corretti; Hunter C Champion; Theodore P Abraham; Reda E Girgis; Paul M Hassoun
Journal:  Am J Respir Crit Care Med       Date:  2006-08-03       Impact factor: 21.405

5.  Evaluation of methods for estimation of total arterial compliance.

Authors:  N Stergiopulos; J J Meister; N Westerhof
Journal:  Am J Physiol       Date:  1995-04

6.  Pulmonary vascular response patterns during exercise in left ventricular systolic dysfunction predict exercise capacity and outcomes.

Authors:  Gregory D Lewis; Ryan M Murphy; Ravi V Shah; Paul P Pappagianopoulos; Rajeev Malhotra; Kenneth D Bloch; David M Systrom; Marc J Semigran
Journal:  Circ Heart Fail       Date:  2011-02-03       Impact factor: 8.790

7.  Quantification of right ventricular afterload in patients with and without pulmonary hypertension.

Authors:  Jan-Willem Lankhaar; Nico Westerhof; Theo J C Faes; Koen M J Marques; J Tim Marcus; Piet E Postmus; Anton Vonk-Noordegraaf
Journal:  Am J Physiol Heart Circ Physiol       Date:  2006-05-12       Impact factor: 4.733

8.  Continuous subcutaneous infusion of treprostinil, a prostacyclin analogue, in patients with pulmonary arterial hypertension: a double-blind, randomized, placebo-controlled trial.

Authors:  Gerald Simonneau; Robyn J Barst; Nazzareno Galie; Robert Naeije; Stuart Rich; Robert C Bourge; Anne Keogh; Ronald Oudiz; Adaani Frost; Shelmer D Blackburn; James W Crow; Lewis J Rubin
Journal:  Am J Respir Crit Care Med       Date:  2002-03-15       Impact factor: 21.405

9.  Survival in patients with primary pulmonary hypertension. Results from a national prospective registry.

Authors:  G E D'Alonzo; R J Barst; S M Ayres; E H Bergofsky; B H Brundage; K M Detre; A P Fishman; R M Goldring; B M Groves; J T Kernis
Journal:  Ann Intern Med       Date:  1991-09-01       Impact factor: 25.391

10.  A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension.

Authors:  R J Barst; L J Rubin; W A Long; M D McGoon; S Rich; D B Badesch; B M Groves; V F Tapson; R C Bourge; B H Brundage; S K Koerner; D Langleben; C A Keller; S Murali; B F Uretsky; L M Clayton; M M Jöbsis; S D Blackburn; D Shortino; J W Crow
Journal:  N Engl J Med       Date:  1996-02-01       Impact factor: 91.245

View more
  104 in total

1.  Pulmonary Arterial Stiffness: Toward a New Paradigm in Pulmonary Arterial Hypertension Pathophysiology and Assessment.

Authors:  Michal Schäfer; Cynthia Myers; R Dale Brown; Maria G Frid; Wei Tan; Kendall Hunter; Kurt R Stenmark
Journal:  Curr Hypertens Rep       Date:  2016-01       Impact factor: 5.369

2.  The relationship of pulmonary vascular resistance and compliance to pulmonary artery wedge pressure during submaximal exercise in healthy older adults.

Authors:  Stephen P Wright; John T Granton; Sam Esfandiari; Jack M Goodman; Susanna Mak
Journal:  J Physiol       Date:  2016-03-24       Impact factor: 5.182

Review 3.  Pulmonary Hypertension Due to Left Heart Disease: an Update.

Authors:  Mandar A Aras; Mitchell A Psotka; Teresa De Marco
Journal:  Curr Cardiol Rep       Date:  2019-05-27       Impact factor: 2.931

4.  Impact of pulmonary endarterectomy on pulmonary arterial wave propagation and reservoir function.

Authors:  Junjing Su; Alun D Hughes; Ulf Simonsen; Jens Erik Nielsen-Kudsk; Kim H Parker; Luke S Howard; Soren Mellemkjaer
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-06-21       Impact factor: 4.733

5.  Management of severe pulmonary hypertension in patients undergoing mitral valve surgery.

Authors:  Carlos D Davila; Paul R Forfia
Journal:  Curr Treat Options Cardiovasc Med       Date:  2015-06

Review 6.  Role of extracellular matrix in the pathogenesis of pulmonary arterial hypertension.

Authors:  Thenappan Thenappan; Stephen Y Chan; E Kenneth Weir
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-08-24       Impact factor: 4.733

7.  Cardiac output response to exercise in relation to metabolic demand in heart failure with preserved ejection fraction.

Authors:  Muaz M Abudiab; Margaret M Redfield; Vojtech Melenovsky; Thomas P Olson; David A Kass; Bruce D Johnson; Barry A Borlaug
Journal:  Eur J Heart Fail       Date:  2013-02-20       Impact factor: 15.534

8.  Pulmonary endarterectomy in chronic thromboembolic pulmonary hypertension: How can patients be better selected?

Authors:  Juan C Grignola; Enric Domingo
Journal:  World J Cardiol       Date:  2013-03-26

9.  Prognostic value of the pre-transplant diastolic pulmonary artery pressure-to-pulmonary capillary wedge pressure gradient in cardiac transplant recipients with pulmonary hypertension.

Authors:  Ryan J Tedford; Claude A Beaty; Stephen C Mathai; Todd M Kolb; Rachel Damico; Paul M Hassoun; Peter J Leary; David A Kass; Ashish S Shah
Journal:  J Heart Lung Transplant       Date:  2013-11-28       Impact factor: 10.247

10.  Pulmonary Arterial Compliance in Acute Respiratory Distress Syndrome: Clinical Determinants and Association With Outcome From the Fluid and Catheter Treatment Trial Cohort.

Authors:  Thomas S Metkus; Emmanouil Tampakakis; Christopher J Mullin; Brian A Houston; Todd M Kolb; Stephen C Mathai; Rachel Damico; Bradley A Maron; Paul M Hassoun; Roy G Brower; Ryan J Tedford
Journal:  Crit Care Med       Date:  2017-03       Impact factor: 7.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.